Symyx Technologies has launched the Symyx Contract Development and Manufacturing Organisation (CDMO).
The Symyx CDMO helps biopharmaceutical companies move promising drug candidates to clinical trials faster and more reliably, with integrated formulation development, and preclinical and CGMP fill/finish manufacturing.
It allows faster development of highly optimised and robust drug formulations, so that clinical trials test the efficacy of drug candidates, not the limitations of the formulation.
It also meets preclinical and Phase I and II clinical trial schedules.
